Back
Balchem Corp. 10K Form
Sell
50
BCPC
Balchem Corp.
Last Price:
$159.87
Seasonality Move:
5.54%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | BCPC/Balchem Corp. Quarterly |
2024-02-16 | 10K | BCPC/Balchem Corp. Annual |
2023-10-27 | 10Q | BCPC/Balchem Corp. Quarterly |
2023-07-28 | 10Q | BCPC/Balchem Corp. Quarterly |
2023-04-28 | 10Q | BCPC/Balchem Corp. Quarterly |
2023-02-24 | 10K | BCPC/Balchem Corp. Annual |
Receive BCPC News And Ratings
See the #1 stock for the next 7 days that we like better than BCPC
BCPC Financial Statistics
Sales & Book Value
Annual Sales: | $953.7M |
---|---|
Cash Flow: | $40.4M |
Price / Cash Flow: | 34.27 |
Annual Sales: | $39.07 |
Price / Book: | 4.11 |
Profitability
EPS (TTM): | 4.36000 |
---|---|
Net Income (TTM): | $142.8M |
Gross Margin: | $336.2M |
Return on Equity: | 12.07% |
Return on Assets: | 8.84% |
Balchem Corp. Earnings Forecast
Key Balchem Corp. Financial Ratios
-
The Gross Profit Margin over the past 41 years for BCPC is 35.25%.
-
The Selling, General & Administrative Expenses for BCPC have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 1.76% of Revenue.
-
The Interest Expense is 12.86% of Operating Income.
-
The Net Earning history of BCPC is 13.47% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 34 years.
Balchem Corp. Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Chemicals |
Sector: | Materials |
Current Symbol: | BCPC |
CUSIP: | 057665 |
Website: | balchem.com |
Debt
Debt-to-Equity Ratio: | 0.16 |
---|---|
Current Ratio: | 2.64 |
Quick Ratio: | 1.43 |
Price-to-Earnings
Trailing P/E Ratio: | 40.82 |
---|---|
Forward P/E Ratio: | 29.17 |
BCPC Technical Analysis vs Fundamental Analysis
Sell
50
Balchem Corp. (BCPC)
is a Sell
Is Balchem Corp. a Buy or a Sell?
-
Balchem Corp. stock is rated a SellThe current Balchem Corp. [BCPC] share price is $160.41. The Score for BCPC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.